Tulsa ER & Hospital in the US is implementing the MeMed BV test that can differentiate between a bacterial and viral infection from serum in just 15 minutes.
The accredited state-licensed hospital provides 24/7 emergency and inpatient care to the Tulsa area and serves the community with latest testing and diagnostics.
Tulsa ER & Hospital chief medical officer and ER Physician Dr Mark Blubaugh said: “We at Tulsa ER & Hospital are excited to offer the new Memed BV test. The FDA-approved lab test will assist us in deciphering between viral and bacterial infections when conventional testing fails to do so.
“The 15-minute results will help guide physicians in the appropriate utilisation of antibiotics. We look forward to continuing to serve the Tulsa community by providing quality state-of-the-art emergency room and inpatient hospital care.”
By applying machine learning MeMed’s technology can translate the complex signaling of the immune system into simple, actionable diagnostic insights.
This approach enables quick and precise diagnosis even in cases where the infection site is not accessible, such as respiratory tract infections.
Additionally, the MeMed BV test enables physicians to enhance patient management and make informed decisions related to antibiotic treatment.
Tulsa ER & Hospital chief nursing officer Rusty McGuire said: “Our hope is this test will offer peace of mind to patients that their symptoms are indeed a viral infection not requiring an unnecessary antibiotic or a bacterial infection where antibiotics are indicated.”
Nutex Health and individual physicians jointly own Tulsa ER & Hospital, which aims to restore the provider and patient relationship through individualised treatment plans and communication.